PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan

Nurgozhin, T.Yermekbaeva, B.Topachevskyi, O.2017-12-142017-12-142012-11-01T. Nurgozhin, B. Yermekbaeva, O. Topachevskyi, PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in Kazakhstan, In Value in Health, Volume 15, Issue 7, 2012, Page A39810983015https://www.sciencedirect.com/science/article/pii/S1098301512028513http://nur.nu.edu.kz/handle/123456789/2897To evaluate cost–effectiveness of pneumococcal vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) compared with 13-valent pneumococcal conjugate vaccine (PCV-13) and no vaccination in Kazakhstan.PIN71 The Potential Public Health Benefit of Pneumococcal Conjugate Vaccines in KazakhstanArticleCopyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.